Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|December 27, 2011
The discovery of potent antagonists of NPBWR1 (GPR7)F Anthony Romero, Nicholas B Hastings, Remond Moningka, et al.Bioorganic & Medicinal Chemistry Letters|April 18, 2021
Discovery of a new series of PI3K-δ inhibitors from Virtual ScreeningXavier Fradera, Qiaolin Deng, Abdelganhi Achab, et al.Bioorganic & Medicinal Chemistry Letters|August 18, 2009
Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitorsHong C Shen, Fa-Xiang Ding, Qiaolin Deng, et al.Bioorganic & Medicinal Chemistry Letters|June 2, 2009
Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitorsHong C Shen, Fa-Xiang Ding, Siyi Wang, et al.ACS Medicinal Chemistry Letters|May 6, 2015
Discovery of benzimidazole oxazolidinediones as novel and selective nonsteroidal mineralocorticoid receptor antagonistsChristine Yang, Jaume Balsells, Hong D Chu, et al.Bioorganic & Medicinal Chemistry Letters|July 11, 2008
Discovery of imidazole carboxamides as potent and selective CCK1R agonistsCheng Zhu, Alexa R Hansen, Thomas Bateman, et al.Journal of Medicinal Chemistry|August 4, 2009
Discovery of a highly potent, selective, and bioavailable soluble epoxide hydrolase inhibitor with excellent ex vivo target engagementHong C Shen, Fa-Xiang Ding, Siyi Wang, et al.Bioorganic & Medicinal Chemistry Letters|January 24, 2017
The design and synthesis of novel spirocyclic heterocyclic sulfone ROMK inhibitors as diureticsHarry R Chobanian, Yan Guo, Barbara Pio, et al.Bioorganic & Medicinal Chemistry Letters|April 23, 2017
Improvement of hERG-ROMK index of spirocyclic ROMK inhibitors through scaffold optimization and incorporation of novel pharmacophoresShuzhi Dong, Kelsey VanGelder, Zhi-Cai Shi, et al.ACS Medicinal Chemistry Letters|July 21, 2016
Discovery of MK-7145, an Oral Small Molecule ROMK Inhibitor for the Treatment of Hypertension and Heart FailureHaifeng Tang, Yuping Zhu, Nardos Teumelsan, et al.Pageof 3